認知症・運動障害治療の世界市場（～2026年）

• 英文タイトル：Global Dementia and Movement Disorder Treatment Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY11592 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料は認知症・運動障害治療のグローバル市場について調査・分析したレポートです。種類別（MAO阻害剤（モノアミン酸化酵素）、AChE阻害剤（アセチルコリンエステラーゼ）、グルタミン酸阻害剤）市場規模、用途別（ブランド薬品、ジェネリック薬品）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別認知症・運動障害治療の競争状況、市場シェア ・世界の認知症・運動障害治療市場：種類別市場規模 2015年-2020年（MAO阻害剤（モノアミン酸化酵素）、AChE阻害剤（アセチルコリンエステラーゼ）、グルタミン酸阻害剤） ・世界の認知症・運動障害治療市場：種類別市場規模予測 2021年-2026年（MAO阻害剤（モノアミン酸化酵素）、AChE阻害剤（アセチルコリンエステラーゼ）、グルタミン酸阻害剤） ・世界の認知症・運動障害治療市場：用途別市場規模 2015年-2020年（ブランド薬品、ジェネリック薬品） ・世界の認知症・運動障害治療市場：用途別市場規模予測 2021年-2026年（ブランド薬品、ジェネリック薬品） ・北米の認知症・運動障害治療市場分析：米国、カナダ ・ヨーロッパの認知症・運動障害治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの認知症・運動障害治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の認知症・運動障害治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの認知症・運動障害治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Allergan、Eisai、Novartis、Teva Pharmaceutical Industries、Amgen、Pfizer、UCB、H. Lundbeck、F. Hoffmann-La Roche、Eli Lilly ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論

Dementia is a collective term for disorders characterized by progressive degeneration of the brain. It impairs memory and affects behavioral, emotional, and cognitive abilities. The neuronal death or neuronal malfunction associated with the disorder manifests as shifts in mood and personality changes, difficulty in performing activities, loss of memory, and aphasia.
The treatment for dementia is conducted through therapeutic approaches that provide symptomatic relief as the drugs intended for the treatment only treat the symptoms. The existing drugs in the market are unable to attack the underlying cause of the disease and prolong the treatment cost and time duration. This will in turn increase the demand for DMD since it will safely modify the progression of a disease.

Market Analysis and Insights: Global Dementia and Movement Disorder Treatment Market
The global Dementia and Movement Disorder Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Dementia and Movement Disorder Treatment Scope and Market Size
Dementia and Movement Disorder Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Dementia and Movement Disorder Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Allergan
Eisai
Novartis
Teva Pharmaceutical Industries
Amgen
Pfizer
UCB
H. Lundbeck
F. Hoffmann-La Roche
Eli Lilly

Market segment by Type, the product can be split into
MAO inhibitors (monoamine oxidase)
AChE inhibitors (acetylcholinesterase)
Glutamate inhibitors
Market segment by Application, split into
Branded drugs
Generic drugs

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Dementia and Movement Disorder Treatment Revenue
1.4 Market by Type
1.4.1 Global Dementia and Movement Disorder Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 MAO inhibitors (monoamine oxidase)
1.4.3 AChE inhibitors (acetylcholinesterase)
1.4.4 Glutamate inhibitors
1.5 Market by Application
1.5.1 Global Dementia and Movement Disorder Treatment Market Share by Application: 2020 VS 2026
1.5.2 Branded drugs
1.5.3 Generic drugs
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Dementia and Movement Disorder Treatment Market Perspective (2015-2026)
2.2 Global Dementia and Movement Disorder Treatment Growth Trends by Regions
2.2.1 Dementia and Movement Disorder Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Dementia and Movement Disorder Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Dementia and Movement Disorder Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Dementia and Movement Disorder Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Dementia and Movement Disorder Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Dementia and Movement Disorder Treatment Players by Market Size
3.1.1 Global Top Dementia and Movement Disorder Treatment Players by Revenue (2015-2020)
3.1.2 Global Dementia and Movement Disorder Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Dementia and Movement Disorder Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Dementia and Movement Disorder Treatment Market Concentration Ratio
3.2.1 Global Dementia and Movement Disorder Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Dementia and Movement Disorder Treatment Revenue in 2019
3.3 Dementia and Movement Disorder Treatment Key Players Head office and Area Served
3.4 Key Players Dementia and Movement Disorder Treatment Product Solution and Service
3.5 Date of Enter into Dementia and Movement Disorder Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Dementia and Movement Disorder Treatment Historic Market Size by Type (2015-2020)
4.2 Global Dementia and Movement Disorder Treatment Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Dementia and Movement Disorder Treatment Market Size by Application (2015-2020)
5.2 Global Dementia and Movement Disorder Treatment Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Dementia and Movement Disorder Treatment Market Size (2015-2020)
6.2 Dementia and Movement Disorder Treatment Key Players in North America (2019-2020)
6.3 North America Dementia and Movement Disorder Treatment Market Size by Type (2015-2020)
6.4 North America Dementia and Movement Disorder Treatment Market Size by Application (2015-2020)

7 Europe
7.1 Europe Dementia and Movement Disorder Treatment Market Size (2015-2020)
7.2 Dementia and Movement Disorder Treatment Key Players in Europe (2019-2020)
7.3 Europe Dementia and Movement Disorder Treatment Market Size by Type (2015-2020)
7.4 Europe Dementia and Movement Disorder Treatment Market Size by Application (2015-2020)

8 China
8.1 China Dementia and Movement Disorder Treatment Market Size (2015-2020)
8.2 Dementia and Movement Disorder Treatment Key Players in China (2019-2020)
8.3 China Dementia and Movement Disorder Treatment Market Size by Type (2015-2020)
8.4 China Dementia and Movement Disorder Treatment Market Size by Application (2015-2020)

9 Japan
9.1 Japan Dementia and Movement Disorder Treatment Market Size (2015-2020)
9.2 Dementia and Movement Disorder Treatment Key Players in Japan (2019-2020)
9.3 Japan Dementia and Movement Disorder Treatment Market Size by Type (2015-2020)
9.4 Japan Dementia and Movement Disorder Treatment Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Dementia and Movement Disorder Treatment Market Size (2015-2020)
10.2 Dementia and Movement Disorder Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Dementia and Movement Disorder Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Dementia and Movement Disorder Treatment Market Size by Application (2015-2020)

11 India
11.1 India Dementia and Movement Disorder Treatment Market Size (2015-2020)
11.2 Dementia and Movement Disorder Treatment Key Players in India (2019-2020)
11.3 India Dementia and Movement Disorder Treatment Market Size by Type (2015-2020)
11.4 India Dementia and Movement Disorder Treatment Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Dementia and Movement Disorder Treatment Market Size (2015-2020)
12.2 Dementia and Movement Disorder Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Dementia and Movement Disorder Treatment Market Size by Type (2015-2020)
12.4 Central & South America Dementia and Movement Disorder Treatment Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Allergan
13.1.1 Allergan Company Details
13.1.2 Allergan Business Overview
13.1.3 Allergan Dementia and Movement Disorder Treatment Introduction
13.1.4 Allergan Revenue in Dementia and Movement Disorder Treatment Business (2015-2020))
13.1.5 Allergan Recent Development
13.2 Eisai
13.2.1 Eisai Company Details
13.2.2 Eisai Business Overview
13.2.3 Eisai Dementia and Movement Disorder Treatment Introduction
13.2.4 Eisai Revenue in Dementia and Movement Disorder Treatment Business (2015-2020)
13.2.5 Eisai Recent Development
13.3 Novartis
13.3.1 Novartis Company Details
13.3.2 Novartis Business Overview
13.3.3 Novartis Dementia and Movement Disorder Treatment Introduction
13.3.4 Novartis Revenue in Dementia and Movement Disorder Treatment Business (2015-2020)
13.3.5 Novartis Recent Development
13.4 Teva Pharmaceutical Industries
13.4.1 Teva Pharmaceutical Industries Company Details
13.4.2 Teva Pharmaceutical Industries Business Overview
13.4.3 Teva Pharmaceutical Industries Dementia and Movement Disorder Treatment Introduction
13.4.4 Teva Pharmaceutical Industries Revenue in Dementia and Movement Disorder Treatment Business (2015-2020)
13.4.5 Teva Pharmaceutical Industries Recent Development
13.5 Amgen
13.5.1 Amgen Company Details
13.5.2 Amgen Business Overview
13.5.3 Amgen Dementia and Movement Disorder Treatment Introduction
13.5.4 Amgen Revenue in Dementia and Movement Disorder Treatment Business (2015-2020)
13.5.5 Amgen Recent Development
13.6 Pfizer
13.6.1 Pfizer Company Details
13.6.2 Pfizer Business Overview
13.6.3 Pfizer Dementia and Movement Disorder Treatment Introduction
13.6.4 Pfizer Revenue in Dementia and Movement Disorder Treatment Business (2015-2020)
13.6.5 Pfizer Recent Development
13.7 UCB
13.7.1 UCB Company Details
13.7.2 UCB Business Overview
13.7.3 UCB Dementia and Movement Disorder Treatment Introduction
13.7.4 UCB Revenue in Dementia and Movement Disorder Treatment Business (2015-2020)
13.7.5 UCB Recent Development
13.8 H. Lundbeck
13.8.1 H. Lundbeck Company Details
13.8.2 H. Lundbeck Business Overview
13.8.3 H. Lundbeck Dementia and Movement Disorder Treatment Introduction
13.8.4 H. Lundbeck Revenue in Dementia and Movement Disorder Treatment Business (2015-2020)
13.8.5 H. Lundbeck Recent Development
13.9 F. Hoffmann-La Roche
13.9.1 F. Hoffmann-La Roche Company Details
13.9.2 F. Hoffmann-La Roche Business Overview
13.9.3 F. Hoffmann-La Roche Dementia and Movement Disorder Treatment Introduction
13.9.4 F. Hoffmann-La Roche Revenue in Dementia and Movement Disorder Treatment Business (2015-2020)
13.9.5 F. Hoffmann-La Roche Recent Development
13.10 Eli Lilly
13.10.1 Eli Lilly Company Details
13.10.2 Eli Lilly Business Overview
13.10.3 Eli Lilly Dementia and Movement Disorder Treatment Introduction
13.10.4 Eli Lilly Revenue in Dementia and Movement Disorder Treatment Business (2015-2020)
13.10.5 Eli Lilly Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Dementia and Movement Disorder Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Dementia and Movement Disorder Treatment Revenue
Table 3. Ranking of Global Top Dementia and Movement Disorder Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Dementia and Movement Disorder Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of MAO inhibitors (monoamine oxidase)
Table 6. Key Players of AChE inhibitors (acetylcholinesterase)
Table 7. Key Players of Glutamate inhibitors
Table 8. Global Dementia and Movement Disorder Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Dementia and Movement Disorder Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Dementia and Movement Disorder Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Dementia and Movement Disorder Treatment Market Share by Regions (2015-2020)
Table 12. Global Dementia and Movement Disorder Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Dementia and Movement Disorder Treatment Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Dementia and Movement Disorder Treatment Market Growth Strategy
Table 18. Main Points Interviewed from Key Dementia and Movement Disorder Treatment Players
Table 19. Global Dementia and Movement Disorder Treatment Revenue by Players (2015-2020) (Million US$)
Table 20. Global Dementia and Movement Disorder Treatment Market Share by Players (2015-2020)
Table 21. Global Top Dementia and Movement Disorder Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dementia and Movement Disorder Treatment as of 2019)
Table 22. Global Dementia and Movement Disorder Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Dementia and Movement Disorder Treatment Product Solution and Service
Table 25. Date of Enter into Dementia and Movement Disorder Treatment Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Dementia and Movement Disorder Treatment Market Size by Type (2015-2020) (Million US$)
Table 28. Global Dementia and Movement Disorder Treatment Market Size Share by Type (2015-2020)
Table 29. Global Dementia and Movement Disorder Treatment Revenue Market Share by Type (2021-2026)
Table 30. Global Dementia and Movement Disorder Treatment Market Size Share by Application (2015-2020)
Table 31. Global Dementia and Movement Disorder Treatment Market Size by Application (2015-2020) (Million US$)
Table 32. Global Dementia and Movement Disorder Treatment Market Size Share by Application (2021-2026)
Table 33. North America Key Players Dementia and Movement Disorder Treatment Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Dementia and Movement Disorder Treatment Market Share (2019-2020)
Table 35. North America Dementia and Movement Disorder Treatment Market Size by Type (2015-2020) (Million US$)
Table 36. North America Dementia and Movement Disorder Treatment Market Share by Type (2015-2020)
Table 37. North America Dementia and Movement Disorder Treatment Market Size by Application (2015-2020) (Million US$)
Table 38. North America Dementia and Movement Disorder Treatment Market Share by Application (2015-2020)
Table 39. Europe Key Players Dementia and Movement Disorder Treatment Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Dementia and Movement Disorder Treatment Market Share (2019-2020)
Table 41. Europe Dementia and Movement Disorder Treatment Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Dementia and Movement Disorder Treatment Market Share by Type (2015-2020)
Table 43. Europe Dementia and Movement Disorder Treatment Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Dementia and Movement Disorder Treatment Market Share by Application (2015-2020)
Table 45. China Key Players Dementia and Movement Disorder Treatment Revenue (2019-2020) (Million US$)
Table 46. China Key Players Dementia and Movement Disorder Treatment Market Share (2019-2020)
Table 47. China Dementia and Movement Disorder Treatment Market Size by Type (2015-2020) (Million US$)
Table 48. China Dementia and Movement Disorder Treatment Market Share by Type (2015-2020)
Table 49. China Dementia and Movement Disorder Treatment Market Size by Application (2015-2020) (Million US$)
Table 50. China Dementia and Movement Disorder Treatment Market Share by Application (2015-2020)
Table 51. Japan Key Players Dementia and Movement Disorder Treatment Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Dementia and Movement Disorder Treatment Market Share (2019-2020)
Table 53. Japan Dementia and Movement Disorder Treatment Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Dementia and Movement Disorder Treatment Market Share by Type (2015-2020)
Table 55. Japan Dementia and Movement Disorder Treatment Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Dementia and Movement Disorder Treatment Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Dementia and Movement Disorder Treatment Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Dementia and Movement Disorder Treatment Market Share (2019-2020)
Table 59. Southeast Asia Dementia and Movement Disorder Treatment Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Dementia and Movement Disorder Treatment Market Share by Type (2015-2020)
Table 61. Southeast Asia Dementia and Movement Disorder Treatment Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Dementia and Movement Disorder Treatment Market Share by Application (2015-2020)
Table 63. India Key Players Dementia and Movement Disorder Treatment Revenue (2019-2020) (Million US$)
Table 64. India Key Players Dementia and Movement Disorder Treatment Market Share (2019-2020)
Table 65. India Dementia and Movement Disorder Treatment Market Size by Type (2015-2020) (Million US$)
Table 66. India Dementia and Movement Disorder Treatment Market Share by Type (2015-2020)
Table 67. India Dementia and Movement Disorder Treatment Market Size by Application (2015-2020) (Million US$)
Table 68. India Dementia and Movement Disorder Treatment Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Dementia and Movement Disorder Treatment Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Dementia and Movement Disorder Treatment Market Share (2019-2020)
Table 71. Central & South America Dementia and Movement Disorder Treatment Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Dementia and Movement Disorder Treatment Market Share by Type (2015-2020)
Table 73. Central & South America Dementia and Movement Disorder Treatment Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Dementia and Movement Disorder Treatment Market Share by Application (2015-2020)
Table 75. Allergan Company Details
Table 76. Allergan Business Overview
Table 77. Allergan Product
Table 78. Allergan Revenue in Dementia and Movement Disorder Treatment Business (2015-2020) (Million US$)
Table 79. Allergan Recent Development
Table 80. Eisai Company Details
Table 81. Eisai Business Overview
Table 82. Eisai Product
Table 83. Eisai Revenue in Dementia and Movement Disorder Treatment Business (2015-2020) (Million US$)
Table 84. Eisai Recent Development
Table 85. Novartis Company Details
Table 86. Novartis Business Overview
Table 87. Novartis Product
Table 88. Novartis Revenue in Dementia and Movement Disorder Treatment Business (2015-2020) (Million US$)
Table 89. Novartis Recent Development
Table 90. Teva Pharmaceutical Industries Company Details
Table 91. Teva Pharmaceutical Industries Business Overview
Table 92. Teva Pharmaceutical Industries Product
Table 93. Teva Pharmaceutical Industries Revenue in Dementia and Movement Disorder Treatment Business (2015-2020) (Million US$)
Table 94. Teva Pharmaceutical Industries Recent Development
Table 95. Amgen Company Details
Table 96. Amgen Business Overview
Table 97. Amgen Product
Table 98. Amgen Revenue in Dementia and Movement Disorder Treatment Business (2015-2020) (Million US$)
Table 99. Amgen Recent Development
Table 100. Pfizer Company Details
Table 101. Pfizer Business Overview
Table 102. Pfizer Product
Table 103. Pfizer Revenue in Dementia and Movement Disorder Treatment Business (2015-2020) (Million US$)
Table 104. Pfizer Recent Development
Table 105. UCB Company Details
Table 106. UCB Business Overview
Table 107. UCB Product
Table 108. UCB Revenue in Dementia and Movement Disorder Treatment Business (2015-2020) (Million US$)
Table 109. UCB Recent Development
Table 110. H. Lundbeck Business Overview
Table 111. H. Lundbeck Product
Table 112. H. Lundbeck Company Details
Table 113. H. Lundbeck Revenue in Dementia and Movement Disorder Treatment Business (2015-2020) (Million US$)
Table 114. H. Lundbeck Recent Development
Table 115. F. Hoffmann-La Roche Company Details
Table 116. F. Hoffmann-La Roche Business Overview
Table 117. F. Hoffmann-La Roche Product
Table 118. F. Hoffmann-La Roche Revenue in Dementia and Movement Disorder Treatment Business (2015-2020) (Million US$)
Table 119. F. Hoffmann-La Roche Recent Development
Table 120. Eli Lilly Company Details
Table 121. Eli Lilly Business Overview
Table 122. Eli Lilly Product
Table 123. Eli Lilly Revenue in Dementia and Movement Disorder Treatment Business (2015-2020) (Million US$)
Table 124. Eli Lilly Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Dementia and Movement Disorder Treatment Market Share by Type: 2020 VS 2026
Figure 2. MAO inhibitors (monoamine oxidase) Features
Figure 3. AChE inhibitors (acetylcholinesterase) Features
Figure 4. Glutamate inhibitors Features
Figure 5. Global Dementia and Movement Disorder Treatment Market Share by Application: 2020 VS 2026
Figure 6. Branded drugs Case Studies
Figure 7. Generic drugs Case Studies
Figure 8. Dementia and Movement Disorder Treatment Report Years Considered
Figure 9. Global Dementia and Movement Disorder Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Dementia and Movement Disorder Treatment Market Share by Regions: 2020 VS 2026
Figure 11. Global Dementia and Movement Disorder Treatment Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Dementia and Movement Disorder Treatment Market Share by Players in 2019
Figure 14. Global Top Dementia and Movement Disorder Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dementia and Movement Disorder Treatment as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Dementia and Movement Disorder Treatment Revenue in 2019
Figure 16. North America Dementia and Movement Disorder Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Dementia and Movement Disorder Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Dementia and Movement Disorder Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Dementia and Movement Disorder Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Dementia and Movement Disorder Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Dementia and Movement Disorder Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Dementia and Movement Disorder Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed

---